Navigation Links
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
Date:8/11/2008

involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that human clinical trials can be conducted and completed in an efficient and successful manner, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, that our products or product candidates will prove to be sufficiently safe and effective, that necessary regulatory approvals will be obtained, that third parties on whom we depend will perform as anticipated, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our ability to successfully accelerate the commercialization of our therapeutic hypothermia devices and launch new devices within the timeframes contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release pu
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
4. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
7. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
9. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
10. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
11. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... WASHINGTON, New York , July ... Neue Partnerschaft für umfassenden Schutz ... Medikamenteneinwirkungen in Österreich    ... Anbieter von geschlossenen Transfersystemen (Closed System Transfer Devices, CSTDs) ... Medikus , einen Vertriebshändler und Hersteller ...
(Date:7/22/2014)... July 22, 2014 ... company focused on solid dose formulations of therapeutics ... formulation of octreotide acetate achieved successful results in ... currently marketed liquid product (Sandostatin®).  Based on these ... production process to a contract manufacturing organisation (CMO), ...
(Date:7/21/2014)... , July 21, 2014 McCord ... patent (U.S. Patent No. 8,796,315). This patent describes ... wound healing.  According to the inventor, Dr. McCord, ... who require wound healing, a composition of an ... derived from umbilical cord blood, such that the ...
Breaking Medicine Technology:Equashield ernennt Medikus zu seinem exklusiven österreichischen Vertriebspartner für seine geschlossenen Arzneimitteltransfersysteme 2Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2
... N.Y., Jan. 18 On January 17, 2008, the ... LLC, Douglas & London,P.C., Levin Simes Kaiser and Gornick ... have filed over a Billion ($1,000,000,000) Dollar,Class Action lawsuit ... Eastern District of New York, Docket #08-258 before The,Honorable ...
... Embryonic Stem Cell Lines for Therapeutic ... ... has,become the first to report, and painstakingly document, the cloning of a,human ... an,adult donor. The study was published online today by the journal "Stem,Cells.", ...
Cached Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3
(Date:7/22/2014)... "The Big Secrets: Ten Things Every Young Person Should Know ... young people can read. , But be careful! What’s in this ... people have been living with all their lives. And If the ... sex to death, this self-help book deals directly with social reality ... it like it is. , Tune in to “The Big Secrets” ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Kirby Lester, ... medication dispensing device includes streamlined functionality to perform a ... vial-filling robot. , Since a double-count of controlled medications ... hospital pharmacy to quickly perform a second count of ... an archived record of the second count up to ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 MyDiettogo ... as well as community discussion forums, to make it ... improve health. Customers now can track their Diet-to-Go meals, ... same journey, all from their computer or smart phone. ... professional staff Nutritionist and Certified Health Coach. , According ...
(Date:7/22/2014)... One woman who looked at diet pills as ... Unfortunately, the weight loss came at a price – she ... time using the pill, and says her personality changed from ... as a result of the caffeine content of one pill, ... of 37 because of a diet pill she was taking. ...
(Date:7/22/2014)... July 22, 2014 Learning ZoneXpress ... has released its annual Nutrition Catalog for ... features more than 1,000 products including posters, handouts, ... New and best-selling resource topics include MyPlate ... Colorful and inviting, the LZX Nutrition Catalog features ...
Breaking Medicine News(10 mins):Health News:Strategic Book Publishing & Rights Agency Announces the Release of its Newest Title, “The Big Secrets: Ten Things Every Young Person Should Know About and Why” 2Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:Diet-to-Go Introduces New Online and Mobile Weight-Loss Tools, with Apps for iPhone and Android 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Learning ZoneXpress (LZX) Publishes Nutrition Catalog Filled with Creative, Relevant, Affordable Teaching Tools 2Health News:Learning ZoneXpress (LZX) Publishes Nutrition Catalog Filled with Creative, Relevant, Affordable Teaching Tools 3
... Mango, the very popular and fastest-growing retailer of authentic ... "AKA" seal, a certification confirming that Red Mango,s frozen ... high quality, delicious treat by nationally recognized Celebrity Dietitian ... and nutritionist in Los Angeles by Citysearch.com for the ...
... Physicians Practice and an alliance of businesses in Bucks ... physicians and their staff more time to devote to ... designed to help doctors in Bucks County better handle ... practice. Members of the Bucks County Partners include Doylestown ...
... (Nasdaq: CYBX ) today announced that the company ... year ended April 24, 2009 on Wednesday, June 3, 2009 ... conference call to discuss those results at 9:00 AM EDT ... Results Conference Call Instructions , To listen to ...
... company that will become public from the planned spinoff ... announced that Edward J. Borkowski has been named chief ... Mylan, Inc. since 2002 where he helped transform the ... the largest generic pharmaceutical companies in the world, operating ...
... receive $10,000 scholarships to help with escalating cost ... effort to promote diversity and help with the ... Medical Association (AMA) Foundation has presented 12 outstanding ... Minority Scholars Awards.The awards recognize scholastic achievement, financial ...
... Surgical Information Systems (SIS) successfully completed ... Integrating the Healthcare Enterprise (IHE) Connectathon, and ... Systems Society (HIMSS) Interoperability Showcase in Chicago.(Logo: ... )The Connectathon is the healthcare IT ...
Cached Medicine News:Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 2Health News:Red Mango Receives 'AKA' Stamp of Approval From Ashley Koff, R.D., Underscoring Its Commitment to Good Health 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 2Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 3Health News:Physicians Practice and Area Businesses Partner to Improve Patient Care in Bucks County, Pennsylvania 4Health News:Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results 2Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 2Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 3Health News:CareFusion Names Edward Borkowski as Chief Financial Officer 4Health News:AMA Foundation Names Minority Scholars Award Recipients 2Health News:SIS Completes IHE Connectathon, Participates in HIMSS Interoperability Showcase 2
... test kit is an enzyme immunometric ... with a liquid phase,incubation, designed for ... serum. The microplate is coated,with anti-rabbit ... to anti-rabbit antibody-coated wells, along with ...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N...
Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease...
IGF-BP3 EIA Endocrine Function 022-IGF-E03 Insulin Growth Factor binding protein...
Medicine Products: